Clinical Oncology Week articles from August 2004

Clinical Oncology Week archives from August 2004

Factors affecting good and poor CD34+ cell mobilization in AML determined.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The factors affecting good and poor CD34+ cell mobilization in AML have been determined. According to a study from Italy, "The factors possibly affecting the collection of peripheral blood stem...

Alemtuzumab effective therapy for CLL with p53 mutations and deletions.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions. "The presence of p53 mutation or deletion predicts for poor response to conventional therapy...

Fertility preservation in females receiving cancer therapy is reviewed.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Fertility preservation in females receiving cancer therapy is reviewed. "In the Unites States alone, >650,000 women will be afflicted by cancer in 2003, and 8% of these cases will be aged "Due...

Study finds ovarian cancer biomarker; potential screening breakthrough.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A study of hundreds of women from four hospitals showing that lysophospholipids are present in high levels in women with ovarian cancer but low in healthy women - a major finding - could lead to a...

Published study reports on radiation therapy for small cell lung cancer.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- For patients with limited stage small cell lung cancer, receiving radiation therapy twice a day is more effective than receiving radiation therapy once a day, so long as there is no break during...

FLT3 mutations in AML adversely associate with CR with intensive chemotherapy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- FLT3 mutations are adversely associated with complete remission in AML patients given intensive chemotherapy. "The prognostic impact of FLT3 mutations on the outcome of patients with diploid AML,...

Sexual behavior changes may explain rising incidence of anal cancer.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Anal cancer is on the rise in both sexes, particularly among American men, and changing trends in sexual behavior - combined with current tobacco use and infection by a specific strain of the human...

Vaccine targeting cancer-related antigens appears to prolong survival.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers seeking to direct cancer-killing immune cells against the deadliest brain tumors have three new targets that show promise in laboratory studies and in a Phase I patient trial, according to...

Alliance formed to increase access to partial breast irradiation.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Varian Medical Systems, Inc. (VAR) and Proxima Therapeutics, Inc. have formed an alliance to increase access to high-dose-rate radiation (HDR) therapy equipment for hospitals interested in offering...

Collaboration to study advanced breast imaging applications.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Hologic, Inc., (HOLX) has entered into a collaborative research agreement with the David Geffen School of Medicine at the University of California at Los Angeles (UCLA) to study a variety of advanced...

Denoising algorithm reduces radiation exposure.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- University of Rochester, New York, radiologists have proposed a denoising algorithm that reduces radiation exposure of a patient undergoing cone-beam computed tomography scan for breast cancer while...

In vivo TLD dosimetry possible in mammography.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Scientists in Australia say that in vivo adjustment in radiation dose for women undergoing mammography is possible using thermoluminescent dosimeters. "While phantoms are used for quality control...

SLN biopsy predicts axillary lymph node status in male breast cancer patients.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers from the University of Wales School of Medicine reported that sentinel node (SLN) biopsy accurately predicted axillary lymph node status in five male study patients with breast cancer. ...

Unwanted support during recovery may backfire.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Women with breast cancer who receive unwanted support have more trouble adjusting to the disease than those who receive no support at all, a new study suggests. Researchers Julie S. Reynolds and...

Licensing agreement forged for antiphospholipid therapy technology.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Peregrine Pharmaceuticals (NASDAQ:PPHM) announced that it has completed a worldwide exclusive licensing agreement for intellectual property related to anti- phosphatidylserine (anti-PS) antibodies. ...

Oncological impact of gene expression profiling reviewed.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The oncological impact of gene expression profiling has been reviewed. "Genomics has enabled the examination of the totality of disease at the transcriptome level," scientists in the United States...

Catalytic antioxidant inhibits tumor regrowth following radiation therapy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Incara Pharmaceuticals Corporation (ICRA) has announced further data that demonstrate that the administration of a compound, AEOL 10113, from the company's class of proprietary catalytic antioxidants...

DNABarrier cancer treatment licensed to Chinese biotechnology corporation.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Mologen announced licensing of its dSLIM-based DNABarrier II to the Chinese biotechnology corporation Starvax Inc. of Beijing, PR China. DNABarrier II is one of three applications currently under...

Effects of P-glycoprotein inhibitors on paclitaxel uptake clarified.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The interaction between the anticancer drug paclitaxel and P-glycoprotein inhibitors has been elucidated. "P-glycoprotein inhibitors can increase the oral bioavailability of paclitaxel,"...

Nanomedicine global developments and growth opportunities explored.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The adoption of nanotechnology-based applications by large therapeutic and diagnostic companies is accelerating the development of nanomedicine. The prospect of site-specific therapeutic action and...

National Cancer Institute grant received to develop multiplex cell assay.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- PharmaSeq announced the receipt of a Phase I SBIR grant from the U.S. National Cancer Institute, a branch of U.S. National Institutes of Health (NIH). The main goal of the research is to develop a...

Patent issued for method to predict effectiveness of chemotherapy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- U.S. Patent and Trademark Office granted patent gene methylation technology for the prediction of clinical response to certain types of chemotherapeutic treatment of cancer patients. The treatment...

Women tend to interpret cervical smear test results correctly.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Answers women gave on a questionnaire about cervical cancer results show most interpreted the results correctly. "Screening for cervical cancer using the Papanicolaou smear test has been available...

MAX2 reproducibly estimates average per patient risk for chemotherapy toxicity.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- MAX2 reproducibly estimates average per patient risk for chemotherapy toxicity. According to recent research published in the European Journal of Cancer, "Cancer patients, especially the elderly,...

IL-11 may improve thrombocytopenia associated with imatinib therapy in CML.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- IL-11 may improve thrombocytopenia associated with imatinib therapy in chronic myelogenous leukemia. According to published research from the United States, "During therapy with imatinib (Gleevec),...

Intracellular thiols, calcium critical in parthenolide-induced apoptosis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers from the National University of Singapore reported that intracellular thiols and calcium played critical roles in parthenolide-induced apoptosis in human colorectal cancer cells. ...

Herbs and spices have antimicrobial and chemopreventive properties.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Herbs and spices have antimicrobial and chemopreventive properties. "Herbs and spices have been used for generations by humans as food and to treat ailments. Scientific evidence is accumulating that...

Methylated DNA collected by tampons detects endometrial cancer.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Methylated DNA collected by tampons detects endometrial cancer. According to recent research published in the journal Cancer Epidemiology Biomarkers & Prevention, "This proof of principle study...

Biopharmaceutical company reports second quarter financial results.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- MGI Pharma, Inc., (MOGN) announced that total revenue for the second quarter of 2004 was $47.9 million, including Aloxi (palonosetron hydrochloride) injection sales of $37.1 million. Net income for...

Cdx2 is present in early gastric cancers.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic...

SLN biopsy practicable for diagnosing cervical, endometrial cancers.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Sentinel lymph node biopsy is feasible as a tool for diagnosing cervical and endometrial cancer, suggest physicians at the Hopital Europeen Georges Pompidou, Paris, France. "The sentinel lymph node...

Peritoneal washing cytology as a diagnostic and prognostic tool reviewed.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pathologists in private practice in Brisbane, Australia, recently reviewed peritoneal washing cytology as a diagnostic and prognostic tool for gynecologic cancers. "Peritoneal washing cytology...

HAART increases survival of patients with HIV-associated Hodgkin disease.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Highly active antiretroviral therapy increases the survival of patients with HIV-associated Hodgkin disease. According to a study from Germany, "Hodgkin disease (HD) is the most common nonacquired...

Cancer-preventive geranylgeranoic acid occurs naturally in medicinal herbs.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- According to published research from Japan, cancer-preventive geranylgeranoic acid occurs naturally in medicinal herbs. Geranylgeranoic acid (GGA; all-trans...

Gene profiles could improve acute leukemia diagnosis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Microarray data will help classify major subtypes of acute myeloid leukemia and speed understanding of the altered biology that causes this cancer in adults and children The results of a microarray...

Novel chemotherapeutic agents promising for malignant mesothelioma.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Novel chemotherapeutic agents appear promising for the treatment of malignant mesothelioma. "We reviewed the published literature of clinical studies in malignant mesothelioma (MM), including phase...

Researchers use human antibody to cure malignant melanoma in mice.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Mayo Clinic researchers have manipulated a human antibody to induce an anti-tumor response in living mice that consistently curbs - and often cures - malignant melanoma, one of the most lethal forms of...

Study results suggest that lumican inhibits melanoma progression.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Results from a French study suggest that lumican inhibits melanoma progression. "Lumican is a member of the small leucine-fich proteoglycan (SLRP) family. It contributes to the organisation of the...

Treatment with 5-FU and celecoxib helps reduce UVB-induced skin tumors in study.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Topical treatment with the chemotherapeutic agent 5-fluorouracil (5-FU) and the COX-2 inhibitor and anti-inflammatory drug celecoxib more effectively reduced the number of ultraviolet light B-induced...

Dermatopathologists play role in diagnosis of Muir-Torre syndrome.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- An article published in the American Journal of Dermatopathology emphasizes the role of the dermatopathologists in the diagnosis of Muir-Torre syndrome. "Muir-Torre syndrome (MTS) is an autosomal...

Intensive chemotherapy alone most cost effective option for stage II/III MM.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Intensive chemotherapy alone is the most cost effective option for stage II/III multiple myeloma. "A prospective randomized phase III study inpatients less than or equal to65 years old with...

Thalidomide's promising future in fighting cancer explored.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- From the late 1950s to the end of 1961, thalidomide was a popular sedative and treatment for morning sickness until it was discovered to cause fetal malformations, which proved fatal within the first...

Findings suggest need for new view of p53 cancer protein's interaction with DNA.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Perhaps the most commonly mutated of all cancer-linked genes is the gene for a tumor suppressor called p53. Scientists estimate that at least half of human cancers involve mutant p53. In the course of...

Marijuana use not associated with oral squamous cell carcinoma risk in study.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Marijuana use was not associated with the development of oral squamous cell carcinoma in a large, population-based study, report U.S. researchers. "Previous laboratory investigations, case reports,...

IND, SPA submitted to FDA for pivotal trial of XYOTAX.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The Gynecologic Oncology Group (GOG) submitted an IND (investigational new drug application) to the U.S. Food and Drug Administration (FDA), including a special protocol assessment (SPA) package, for a...

Biopharmaceutical company appoints vice president, clinical development.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- ImmunoGen, Inc., (IMGN) has appointed Robert J. Fram, MD, FACP, to head its newly established Clinical Department. Fram will lead the development of the company's proprietary clinical-stage...

Multiple endocrine neoplasia 2A complications rare with early diagnosis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- When a woman is diagnosed with multiple endocrine neoplasia 2A (MEN 2A) before she becomes pregnant, complications in both mother and fetus are rare, researchers say. "MEN 2A is an inherited...

Children's Hospital Boston awarded over $500,000 for prostate cancer research.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Three investigators at Children's Hospital Boston have received highly competitive grants from the U.S. Department of Defense (DoD) for research on prostate cancer, totaling more than $500,000. ...

Hormone refractory prostate cancer trial extended to additional Canadian sites.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Lorus Therapeutics Inc. has expanded its hormone refractory prostate cancer (HRPC) trial to two additional sites in Canada. The combination of GTI-2501 and docetaxel in this clinical trial is being...

Advances in proteomic research may lead to early diagnosis of tumors, diseases.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Rapid advances in proteomic research may lead to early diagnosis of tumors and other diseases and to development of prognostic indexes and novel therapies, according to researchers from the United...

Initiation of Xcytrin Phase 2 clinical trial in renal cell carcinoma announced.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc., (NASDAQ:PCYC) announced that it is enrolling patients in a Phase 2 clinical trial of Xcytrin (motexafin gadolinium) Injection. Xcytrin is the company's lead cancer therapeutic...

Gamma probe may help orthopedic surgeons with rib abnormality biopsies.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Orthopedic surgeons should consider gamma probe assisted biopsy of suspicious rib abnormalities, according to researchers from the United States. "Retrieving diagnostic tissue from a rib lesion can...

In vivo study examines THz radiation's response to normal skin.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers from University of Cambridge, England, conducted the first systematic in vivo study examining THz radiation's response to normal skin. "Studies in terahertz (THz) imaging have revealed a...

Increased skin pigmentation may explain photoprotective properties of black skin.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Increased skin pigmentation may explain why black skin is less susceptible than white skin to carcinogenesis, sunburn, and photoaging, according to researchers from the Netherlands. "Black skin is...

Combined stratification of refractory anemia improves prognosis in SCT.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Combined stratification of refractory anemia improves prognosis in stem cell transplantation. "A retrospective analysis of the relationship between the initial classification according to either...

Encephalopathy in pediatric patients after HSCT associated with poor prognosis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Encephalopathy in pediatric patients after hematopoietic stem cell transplantation is associated with a poor prognosis. According to recent research published in the journal Bone Marrow...

GVHD major predictive factor for response to donor lymphocyte infusions in MM.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma. "The graft-versus-myeloma (GVM) effect of donor lymphocyte infusions (DLIs)...

Infused autograft lymphocyte dose affects clinical outcome post-SCT in MM.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The infused autograft lymphocyte dose significantly affects the clinical outcome post-stem cell transplantation in multiple myeloma. "Absolute lymphocyte count at day 15 (ALC-15) after autologous...

Infused cell dose predictive of outcomes after unrelated cord blood transplant.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The infused cell dose is highly predictive of outcomes after unrelated cord blood transplantation. According to published research from Italy, "From July 1995 to December 2001, 42 patients with...

Primary systemic amyloidosis patients have increased survival following PBSCT.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Primary systemic amyloidosis patients have increased survival following peripheral blood stem cell transplantation. According to a study from the United States, "Primary systemic amyloidosis (AL)...

Steroid and cyclosporine A use are risk factors for bone loss following SCT.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Steroid and cyclosporine A use are risk factors for bone loss following stem cell transplantation. "Transplantation-associated bone loss is a well-known phenomenon; however, effects of...

Vascular normalization improves drug penetration in tumors.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Vascular normalization improves drug penetration in tumors. According to recent research published in the journal Cancer Research, "elevated interstitial fluid pressure, a hallmark of solid tumors,...

Bladder-sparing treatment shows promise against cancer.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- For patients with invasive bladder cancer, treatment has typically meant an operation to remove the bladder and nearby organs. This requires up to a week in the hospital and leaves patients with a...

Ablation therapy destroys tumors without scarring.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Image-guided thermal techniques that kill tumors without open surgery or scarring may soon allow women diagnosed with breast cancer to avoid disfigurement to be rid of the disease. "We don't have...

New targeted therapy for treatment of resistant colorectal cancer.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- The drug cetuximab, a promising new targeted therapy better known as Erbitux, offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an...

Removal of pigmented melanocytic volar skin lesions in children not recommended.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Typical pigmented melanocytic volar skin lesions are reported to be very common in Columbian school-aged children, but removal of the lesions is not routinely recommended because a link to acral...

Indicators predict survival/death in pediatric HSCT patients admitted to the ICU.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Indicators predict survival/death in pediatric hematopoietic stem cell transplant patients admitted to an intensive care unit. "The objectives of this study are to identify prognostic factors of...

Hepatic ASC treated with TACE using degradable starch microspheres.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Transcatheter arterial infusion chemotherapy with degradable starch microspheres (DSM) can be effective for adenosquamous carcinoma (ASC) patients. Physicians in Japan described their experience...

Combining brain cancer treatments can give patients more time.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Doctors say a new treatment for brain tumors performed by the Mayfield Clinic in Cincinnati can give terminal patients more time to say goodbye. Some even end up living far beyond what is typical....

Brachytherapy saves breast, decreases treatment time.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Many women are unnecessarily undergoing mastectomy when there is an effective, breast-saving treatment that can be performed in under a week, according to a breast cancer specialist. Robert R....

Breast-feeding associated with reduced risk of breast cancer in BRCA1 carriers.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Breast-feeding for a cumulative total of more than 1 year is associated with a reduced risk of breast cancer in BRCA1 mutation carriers, according to a new study. Studies of the general population...

Computers significantly increase tumor detection rate.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- A computer-aided detection (CAD) system can significantly increase the rate of breast cancer detection, according to a study published in the August 2004 issue of the journal Radiology. In the...

DNA methylation predicts hormonal/nonhormonal breast cancer therapy response.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- DNA methylation predicts hormonal/nonhormonal breast cancer therapy response. "We have generated DNA methylation profiles of 148 human breast tumors and found significant differences in hormone...

Detection method overcomes problem of samples with few cells.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Finding cancer in a tiny drop of body fluid containing relatively few cells now may be possible with a new method of analyzing multiple genes in small samples of DNA, the cellular building blocks of our...

False-negatives for sentinel node positivity increase in breast cancer staging.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- False-negatives results for sentinel node positivity are increased in a new breast cancer staging system. "The sixth and newest edition of the American Joint Committee on Cancer (AJCC) staging...

High-dose chemotherapy: No greater survival benefit for high-risk patients.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- A randomized trial has found that breast cancer patients with four or more positive lymph nodes who receive high-dose chemotherapy with a stem cell transplant have similar survival rates to those who...

New imaging technology could save more women's lives.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Using alternative imaging technologies to supplement mammography could help some 40,000 women dying of breast cancer each year, according to a researcher involved in an unprecedented number of studies...

Radiologist says annual reminder needed for mammography.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Health care providers need to take the initiative and encourage all women over age 40 to have annual mammograms, according to Stephen A. Feig, MD, who helped develop the 2003 American Cancer Society...

Simple test identifies early-stage disease.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- IMI International Medical Innovations Inc. (TSX:IMI; Amex: IME) announced publication of clinical trial results for the company's breast cancer test in the American Cancer Society journal Cancer. ...

Study suggests broader chemotherapy attack may be more effective.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- In the first comprehensive survey of gene activity in each cell type composing normal and malignant breast tissue, scientists at Dana-Farber Cancer Institute have identified genes in noncancerous...

Therapeutics company announces preliminary year-end results.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- NeuTec Pharma plc. announces its preliminary results for the year ended 30 June 2004. NeuTec is developing a portfolio of antibody-based therapeutic products directed towards life threatening...

Physical symptoms appear to predict cancer course.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Physical symptoms that impact quality of life, such as nausea and shortness of breath, may predict shorter survival for patients with terminal cancer. A new study published July 26, 2004, in the...

Biopharmaceutical company announces studies presented at SPORE meeting.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Insmed Incorporated (INSM) announced that two independent studies were recently presented to the National Cancer Institute's (NCI's) 12th Annual Meeting of SPORE, (Specialized Programs of Research...

More research, education about complexities of BRCA1/2 genetic testing.
August 9, 2004... 2004 AUG 9 - (NewsRx.com & NewsRx.net) -- Results from the first direct-to-consumer campaign to market BRCA1/2 testing to the public indicate that further research and additional education are needed to prepare consumers and health care...